DSI - Design Space Inpharmatics

At DSI, we often hear one critical question from clients bringing new therapies to market: “Do I need a BLA or an NDA?”
While both are formal FDA submission pathways, they apply to very different product types and the regulatory expectations for each are just as unique.
In our latest blog, we simplify the comparison:
✅ When to file a BLA vs. an NDA
✅ Key differences in oversight, data requirements, and manufacturing
✅ How hybrid products like ADCs are reviewed
✅ Tips to align your regulatory strategy early
https://bit.ly/4lQH5Fj
If your team is preparing for an IND, NDA, or BLA, this is a must-read.

Navigating Regulatory Challenges in Drug Development with DSI
Regulatory compliance is critical for bringing safe and effective drugs to market. DSI’s regulatory experts help streamline the process by ensuring alignment with industry guidelines. Explore key strategies for overcoming regulatory hurdles. Learn more https://bit.ly/3G5pBG1